Active Release Technique vs. Dynamic Soft Tissue Mobilization for Plantar Pain
Comparison of Active Release Technique Versus Dynamic Soft Tissue Mobilization on Pain, Range of Motion, Functional Outcomes and Disability in Subjects With Plantar
Plantar fasciitis is one of the most common causes of heel pain encountered in musculoskeletal and orthopedic physiotherapy practice. It is characterized by degenerative changes at the origin of the plantar fascia on the medial calcaneal tubercle, leading to pain, stiffness, and functional limitations during weight-bearing activities. Patients typically report sharp heel pain that is most severe during the first steps in the morning or after prolonged rest, which significantly affects gait and daily functional activities.Current evidence suggests that plantar fasciitis is not purely an inflammatory condition but rather a degenerative fasciopathy resulting from repetitive microtrauma, abnormal foot biomechanics, prolonged standing, obesity, and tightness of the gastrosoleus complex. These mechanical stressors lead to microtears, collagen degeneration, and thickening of the plantar fascia, ultimately resulting in chronic pain and disability.Objective of this study is to compare the effectiveness of Active Release Technique and Dynamic Soft Tissue Mobilization on pain, function, and disability in patients with plantar fasciitis. All the subjects who will eligible for the criteria will randomly allocated in to Group A(ART) and Group B(DSTM).Taping will be our baseline treatment.. This study will be a randomized controlled trial conducted at Pro Care Physiotherapy Clinic, Ittefaq Hospital, and Iffat Anwar Medical Complex over a period of four months. A total of 62 participants will be recruited using probability convenient sampling and randomly allocated into two groups. Group A will receive Active Release Technique along with baseline taping, while Group B will receive Dynamic Soft Tissue Mobilization along with baseline taping. Both groups will receive three sessions per week for four weeks.Outcome measures will include the Numerical Pain Rating Scale (NPRS) and Foot Function Index (FFI) to assess pain and functional disability. Assessments will be taken at baseline, 2nd week, and 4th week. Data will be analyzed using SPSS version 24, and both intra-group and inter-group comparisons will be performed using appropriate statistical tests.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
Punjab Province
-
Lahore, Punjab Province, Pakistan, 54000
- University of Management & Technology
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
Age 25 to 60 years. Presence of unilateral plantar fasciitis. Participants with positive Windlass test. Symptoms more than 6 weeks of duration diagnosed by orthopaedician. Reported pain with the first step out of the bed in the morning or with the first step after prolonged immobilization and presence of heel pain with prolonged standing on the medial calcaneal tubercle plantar aponeurosis confirmed by palpation. both male and female will be included. Pain intensity of ≥3 on the Visual Analog Scale (VAS) or Numeric Pain Rating Scale (NPRS).
Participants willing to provide informed consent and comply with the treatment protocol.
Exclusion Criteria:
Reported previous history of cancer, peripheral vascular diseases, lower extremity fractures Had a trauma or history of surgery to the foot or ankle. Diabetic neuropathy. People who have undergone steroid therapy, platelet rich plasma therapy in the past 3 months.
Severe foot deformities (e.g., severe pes planus or pes cavus) requiring specialized management.
Open wounds, skin infections, or allergies preventing the application of taping.
Presence of inflammatory or systemic diseases such as Rheumatoid Arthritis, Ankylosing Spondylitis, or Gout.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Active Release Technique (ART)
The patient will sit in a long-sitting position while the therapist assesses muscle and fascial tightness using their hands. The therapist applies specific pressure along the affected tissue from origin to insertion while the muscle is shortened. The patient is then instructed to lengthen the muscle by dorsiflexing the foot. Each session lasts approximately 10 minutes, three times a week for four weeks, along with baseline taping. |
The patient will sit in a long-sitting position while the therapist assesses muscle and fascial tightness using their hands. The therapist applies specific pressure along the affected tissue from origin to insertion while the muscle is shortened. The patient is then instructed to lengthen the muscle by dorsiflexing the foot. Each session lasts approximately 10 minutes, three times a week for four weeks, along with baseline taping. |
|
Comparateur actif: Dynamic Soft Tissue Mobilization
The therapist will perform 10 minutes of deep, forceful soft tissue mobilization on tight and painful areas of the posterior calf muscles, applying pressure across the muscle fibers medially and laterally. The patient will also perform a passive straight leg raise combined with ankle dorsiflexion using a long belt to improve neural mobility. |
The therapist will perform 10 minutes of deep, forceful soft tissue mobilization on tight and painful areas of the posterior calf muscles, applying pressure across the muscle fibers medially and laterally. The patient will also perform a passive straight leg raise combined with ankle dorsiflexion using a long belt to improve neural mobility. |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Pain by Numerical Rating Scale (NPRS)
Délai: At baseline and after 6 weeks
|
Numeric Rating Scale (NPRS) is most frequently used instruments to measure pain. The 11-point numeric with 0 representing No pain, 1- 3 representing Mild Pain (nagging, annoying, interfering little with ADLs), 4-6 representing Moderate Pains (interferes significantly with ADLs), 7-10 representing Sever Pain (disabling, unable to perform ADLs). |
At baseline and after 6 weeks
|
|
Disability by Foot Function Index (FFI)
Délai: At baseline and after 6 weeks
|
The Foot Function Index (FFI) is a widely used patient-reported outcome measure developed to assess the impact of foot pathology on pain, disability, and activity limitation.The questionnaire consists of 23 items divided into three subscales: Pain (9 items), Disability (9 items), and Activity Limitation (5 items). The questions assess foot pain severity and the extent to which foot problems affect daily functional activities such as walking, standing, climbing stairs, and participation in routine activities. |
At baseline and after 6 weeks
|
|
Joint Range of Motion by Goniometer
Délai: At baseline and after 6 weeks
|
The patient's knee will be flexed to 30°, with the ankle in the anatomical position. The goniometer axis will be placed near the lateral ankle, with the stationary arm aligned along the fibula and the movable arm along the fifth metatarsal. The examiner will measure both passive and active ankle dorsiflexion using a goniometer. The normal range of ankle dorsiflexion is approximately 15°-20°. |
At baseline and after 6 weeks
|
Collaborateurs et enquêteurs
Publications et liens utiles
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Autres numéros d'identification d'étude
- RE-207-2026
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
The results data collected , de-identified individual participant data will be shared.
Délai de partage IPD
6 months after the publication of the manuscript.
Critères d'accès au partage IPD
The data can be requested from the corresponding author.
Type d'informations de prise en charge du partage d'IPD
- PROTOCOLE D'ÉTUDE
- SÈVE
- CIF
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .